Melissa in the Morning: GLP-1 Coverage Controversy

GLP-1 medications have quickly become a major part of the conversation around weight loss and diabetes care — but they’re also creating a major challenge for employers and health insurers. As the cost of these increasingly common medications continues to add up, some companies are scaling back coverage or putting new limits on who qualifies.

That could mean higher out-of-pocket costs or fewer options for some employees — while employers are weighing the potential long-term health benefits against the immediate price tag. We spoke in length about this with Quinnipiac University professor of management and medical sciences, Angela Mattie.